Institute for Media and Communication Policy

Yili Innovation Center Europe, the Institute for Manufacturing and StartLife in the Netherlands jointly hold the Open Innovation Forum

Retrieved on: 
Thursday, July 13, 2023

WAGENINGEN, Netherlands, July 13, 2023 /PRNewswire/ -- From July 5 to 6, 2023, the Open Innovation Forum was held on the campus of Wageningen University and Research (WUR), one of the world's top higher education institutions focusing on agricultural studies in the Netherlands. Organized by the Open Innovation (OI) Forum at the Institute for Manufacturing at the University of Cambridge, the event was hosted by StartLife, a specialised investment organization based in the Netherlands, and Yili Innovation Center Europe under the theme of "Disruptive Food Production Technologies." The purpose of the forum was to advance the upgrading and innovative application of global health food technologies, and in turn provide consumers with more comprehensive health solutions.

Key Points: 
  • Organized by the Open Innovation (OI) Forum at the Institute for Manufacturing at the University of Cambridge, the event was hosted by StartLife, a specialised investment organization based in the Netherlands, and Yili Innovation Center Europe under the theme of "Disruptive Food Production Technologies."
  • Regarding this forum, Dr. Lin Zhu, Open Innovation Manager at Yili Innovation Center Europe, said: "The forum will further promote the high-quality development of the industry, and in turn, provide consumers with healthier, more comprehensive and more nutritious solutions."
  • The Yili Innovation Center Europe has now become a bridge for Yili to connect China with innovative endeavors in Europe and the world at large.
  • "Yili works closely with start-ups that are part of StartLife, through providing them with constructive feedback and guidance regarding innovation and entrepreneurship.

Yili Innovation Center Europe, the Institute for Manufacturing and StartLife in the Netherlands jointly hold the Open Innovation Forum

Retrieved on: 
Thursday, July 13, 2023

WAGENINGEN, Netherlands, July 12, 2023 /PRNewswire/ -- From July 5 to 6, 2023, the Open Innovation Forum was held on the campus of Wageningen University and Research (WUR), one of the world's top higher education institutions focusing on agricultural studies in the Netherlands. Organized by the Open Innovation (OI) Forum at the Institute for Manufacturing at the University of Cambridge, the event was hosted by StartLife, a specialised investment organization based in the Netherlands, and Yili Innovation Center Europe under the theme of "Disruptive Food Production Technologies." The purpose of the forum was to advance the upgrading and innovative application of global health food technologies, and in turn provide consumers with more comprehensive health solutions.

Key Points: 
  • Organized by the Open Innovation (OI) Forum at the Institute for Manufacturing at the University of Cambridge, the event was hosted by StartLife, a specialised investment organization based in the Netherlands, and Yili Innovation Center Europe under the theme of "Disruptive Food Production Technologies."
  • Regarding this forum, Dr. Lin Zhu, Open Innovation Manager at Yili Innovation Center Europe, said: "The forum will further promote the high-quality development of the industry, and in turn, provide consumers with healthier, more comprehensive and more nutritious solutions."
  • The Yili Innovation Center Europe has now become a bridge for Yili to connect China with innovative endeavors in Europe and the world at large.
  • "Yili works closely with start-ups that are part of StartLife, through providing them with constructive feedback and guidance regarding innovation and entrepreneurship.

Industry Veteran Eric Tveter Joins CEA’s Advisory Board

Retrieved on: 
Friday, February 18, 2022

CEA Group (CEA) announced today Eric Tveter, a longtime veteran of the Media and Communications industries, has joined CEA as Senior Advisor for Media and Communications.

Key Points: 
  • CEA Group (CEA) announced today Eric Tveter, a longtime veteran of the Media and Communications industries, has joined CEA as Senior Advisor for Media and Communications.
  • During the past 20 years, Eric has served as CEO to a number of multibillion-dollar revenue companies.
  • His reputation in the communications industry and global contacts will benefit not only CEA, but our clients as well.
  • With a team of experienced personnel worldwide, CEA has an unequaled depth and breadth of industry knowledge, expertise and long-standing industry relationships.

FourQ Introduces Intercompany Financial Management (IFM) Insights

Retrieved on: 
Monday, July 26, 2021

WESTPORT, Conn., July 26, 2021 /PRNewswire-PRWeb/ -- FourQ has launched IFM Insights, a new video discussion series featuring intercompany and shared services leaders.

Key Points: 
  • WESTPORT, Conn., July 26, 2021 /PRNewswire-PRWeb/ -- FourQ has launched IFM Insights, a new video discussion series featuring intercompany and shared services leaders.
  • In each 20-minute IFM Insights episode, an intercompany leader is interviewed about their work, perceptions, challenges, and predictions for the intercompany sphere.
  • Built by finance, accounting, and tax experts, FourQ is Intercompany Financial Management software that streamlines the global operations of the world's largest companies.
  • Providing automated intercompany processing seamlessly integrated with global vendor invoice management, FourQ helps multinational companies increase efficiency and improve global business operations.

IFM Announces Tracy W. Gaudet, MD, as Closing Keynote at 2020 Annual International Conference

Retrieved on: 
Wednesday, May 27, 2020

The Institute for Functional Medicine (IFM) today announced Tracy W. Gaudet, MD , as the closing keynote speaker for IFMs Annual International Conference (AIC) 2020: Advancements in Clinical Research and Innovative Practices in Functional Medicine.

Key Points: 
  • The Institute for Functional Medicine (IFM) today announced Tracy W. Gaudet, MD , as the closing keynote speaker for IFMs Annual International Conference (AIC) 2020: Advancements in Clinical Research and Innovative Practices in Functional Medicine.
  • Dr. Gaudet will be speaking at IFMs Annual International Conference on Uniting Efforts to Transform Health Care.
  • Im thrilled to be participating in AIC 2020 to share in how all of us play a critical role in this transformation.
  • The Institute for Functional Medicine (IFM) is the global leader in Functional Medicine and a collaborator in the transformation of healthcare.

IFM Restoration Closes $10M Series A Funding Round to Disrupt the Skilled Labor Marketplace for Rental Property Maintenance

Retrieved on: 
Thursday, April 9, 2020

The Series A funding represents the first institutional funding from the Dallas-headquartered company, bringing the total venture capital raised by IFM Restoration to $11 million.

Key Points: 
  • The Series A funding represents the first institutional funding from the Dallas-headquartered company, bringing the total venture capital raised by IFM Restoration to $11 million.
  • Having two powerhouse strategic partners like Brick & Mortar and S3 Ventures is a sign of the tailwinds ahead, Daniel Feldman, co-founder, IFM Restoration.
  • IFM Restorations online marketplace presents a huge opportunity for contractors and owners alike, matching skilled tradespeople with available work in their area.
  • IFM Restoration partners with real estate investment trusts and property management companies to simplify the rental property maintenance process.

IFM Therapeutics Appoints Michael Cooke, Ph.D., as Chief Scientific Officer

Retrieved on: 
Tuesday, January 7, 2020

BOSTON, Jan. 7, 2020 /PRNewswire/ -- IFM Therapeutics (IFM), a privately-held biopharmaceutical company focused on developing therapies that modulate novel targets in the innate immune system, today announced the appointment of Michael Cooke, Ph.D., as Chief Scientific Officer.

Key Points: 
  • BOSTON, Jan. 7, 2020 /PRNewswire/ -- IFM Therapeutics (IFM), a privately-held biopharmaceutical company focused on developing therapies that modulate novel targets in the innate immune system, today announced the appointment of Michael Cooke, Ph.D., as Chief Scientific Officer.
  • "At IFM Therapeutics, we have assembled a world-class team of scientists with deep experience translating scientific discovery into transformative therapies that target the innate immune system," said Dr. H. Martin Seidel, Chief Executive Officer of IFM.
  • Dr. Cooke joins IFM from Magenta Therapeutics where he most recently served as Chief Scientific Officer, leading an organization responsible for developing curative medicines for hematologic malignancy, genetic diseases and autoimmune disease through advances in bone marrow transplantation.
  • IFM Therapeutics (IFM) is an independent, privately-held biopharmaceutical company based in Boston, Massachusetts.

The Institute for Functional Medicine Announces AIC 2020: Advancements in Clinical Research and Innovative Practices in Functional Medicine

Retrieved on: 
Monday, January 6, 2020

The Institute for Functional Medicine (IFM) today announced the 2020 IFM Annual International Conference (AIC): Advancements in Clinical Research and Innovative Practices in Functional Medicine.

Key Points: 
  • The Institute for Functional Medicine (IFM) today announced the 2020 IFM Annual International Conference (AIC): Advancements in Clinical Research and Innovative Practices in Functional Medicine.
  • This years conference will focus on the state-of-the-science in Functional Medicine, presenting the latest research that highlights the benefits of Functional Medicine on improving health outcomes.
  • IFM is proud to bring together Functional Medicine professionals from around the globe to discuss the future of Functional Medicine, said Amy R. Mack, CEO of IFM.
  • The Institute for Functional Medicine (IFM) is the global leader in Functional Medicine and a collaborator in the transformation of healthcare.

IFM Governing Board of Directors Continues Planned Leadership Transitions

Retrieved on: 
Friday, December 13, 2019

The Institute for Functional Medicine (IFM) today announced that Joseph E. Pizzorno, ND, has been elected Chairman of its governing Board of Directors.

Key Points: 
  • The Institute for Functional Medicine (IFM) today announced that Joseph E. Pizzorno, ND, has been elected Chairman of its governing Board of Directors.
  • Dr. Pizzorno has been a key contributor to the development of IFM since its inception in 1991, said Jeffrey Bland, PhD, founder of IFM.
  • Current Vice-Chair Juliet Rogers will also transition from the governing Board after serving as a Director since 2013.
  • I am honored to serve as IFMs Board Chairman and pledge my commitment to IFM and the advancement of health and healing.

IFM Therapeutics Announces $55.5 Million Financing to Launch and Fund New Subsidiaries and Appointment of Dr. H. Martin Seidel as Chief Executive Officer

Retrieved on: 
Monday, December 2, 2019

IFM Quattro and IFM Discovery will focus on developing next-generation small molecule immunotherapies for inflammatory diseases and cancers.

Key Points: 
  • IFM Quattro and IFM Discovery will focus on developing next-generation small molecule immunotherapies for inflammatory diseases and cancers.
  • Under the terms of the financing agreement, IFM Discovery will work on a range of targets within the innate immune system.
  • In addition, IFM announced the transition of Chief Executive Officer and Co-Founder Gary D. Glick, Ph.D., into the role of Executive Chairman of the Board.
  • Effective today, IFM's Executive Vice President of Research and Development, H. Martin Seidel, Ph.D., has been named Chief Executive Officer and appointed to the Company's Board of Directors.